Metabolon

Metabolon

Provides actionable biological insights to answer the toughest questions in life sciences research and drug development. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-

$13.1m

Series D

$15.0m

Series E
N/A

$5.0m

Early VC

$15.0m

Debt
N/A

$7.3m

Debt

$72.0m

Growth Equity VC
*
N/A

$25.0m

Late VC
*

N/A

Grant
*

$60.0m

Debt
*

N/A

Grant
Total FundingAUD242m

Recent News about Metabolon

Edit
More about Metaboloninfo icon
Edit

Metabolon, Inc. specializes in providing advanced metabolomics solutions, which involve the large-scale study of small molecules called metabolites within cells, biofluids, tissues, or organisms. The company serves a diverse range of clients, including academic researchers, pharmaceutical companies, and government institutions. Operating in the biotechnology and life sciences market, Metabolon offers a comprehensive suite of services from study design and sample collection to data analysis and biological interpretation. The business model is service-based, generating revenue through contracts and collaborations for metabolomic analysis projects. Metabolon leverages its extensive compound library and integrated bioinformatics platform to deliver high-fidelity results, ensuring reliable and actionable insights for its clients. The company has successfully completed over 10,000 projects for more than 1,300 clients, demonstrating its expertise and reliability in the field.

Keywords: Metabolomics, Biotechnology, Data Analysis, Bioinformatics, Research, Pharmaceuticals, Academic, Government, Biological Insights, Compound Library.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Metabolon

Edit
Lipomics Technologies
ACQUISITION by Metabolon Aug 2012
Metabolomic Discoveries
ACQUISITION by Metabolon Sep 2017